PD27-02 DOES PATIENT AGE AFFECT THE OUTCOMES AND PATIENT REPORTED HEALTH RELATED QUALITY OF LIFE (HRQOL) AFTER SACRAL NEUROMODULATION?

Abstract

You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Female Incontinence - Therapy I1 Apr 2015PD27-02 DOES PATIENT AGE AFFECT THE OUTCOMES AND PATIENT REPORTED HEALTH RELATED QUALITY OF LIFE (HRQOL) AFTER SACRAL NEUROMODULATION? Tyler Lu, Jaspreet Singh Parihar, Bianca Chendrimada, and Hari S.G.R. Tunuguntla Tyler LuTyler Lu More articles by this author , Jaspreet Singh PariharJaspreet Singh Parihar More articles by this author , Bianca ChendrimadaBianca Chendrimada More articles by this author , and Hari S.G.R. TunuguntlaHari S.G.R. Tunuguntla More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.446AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Sacral nerve neuromodulation is an established treatment option for refractory overactive bladder symptoms (OAB, urinary frequency, urgency and urgency incontinence) as well as non-obstructive urinary retention (NOR). In this retrospective cohort study, we aim to determine whether patient age plays a significant role in the outcomes following sacral neuromodulation. METHODS From 2009-2013, all consecutive patients with refractory OAB and NOR treated by a single surgeon were included. Patient symptom severity and satisfaction with therapy were assessed three months postoperatively. Patients were asked on whether they preferred keeping the device or wanted removal (patient reported HRQOL). Patients were categorized into 3 groups (Group 1 [20-40 years]; Group 2 [41-60 years]; and Group 3 [61-80 years]). Each of these 3 groups was subsequently subdivided into 2 subgroups (subgroup a, OAB; subgroup b, NOR). These subgroups are designated as 1a, 1b, 2a, 2b, 3a, and 3b. Descriptive statistics including frequency of distribution and central tendency were calculated for each category. RESULTS A total of 78 patients were included in the study. There was a total of 13 patients in Group 1; 11/13 (85%) presented with OAB and 2/13 (15%) with NOR. In group 1a only, 1 (9.1%) patient requested explant while none requested explant in group 1b. Group 2 comprised of 29 patients with 16 (55%) presenting with OAB symptoms and 13 (45%) with NOR. 3 patients (18.8%) in group 2a and 2 patients (15.4%) in group 2b requested explant. Group 3 comprised of 36 patients with 22 (61%) presenting OAB and 14 (39%) with NOR. 4 patients (18.2%) in group 3a and 1 patient (7.1%) in group 3b had their implants removed. CONCLUSIONS Our study demonstrates that age does not adversely affect the outcomes following sacral neuromodulation in patients with urinary frequency, urgency, urgency incontinence and non-obstructive urinary retention. Group 1 Group 1 Group 2 Group 2 Group 3 Group 3 a [OAB] (n=11) b [NOR] (n=2) a [OAB] (n=16) b [NOR] (n=13) a [OAB] (n=22) b [NOR] (n=14) Implant remained 10 2 13 11 18 13 Implant removed 1 0 3 2 4 1 Rate of device explantation (%) 9% 0% 19% 15% 18% 7% Group 1 [20-40 years-old] (n=13 ), Group 2 [41-60 years-old] (n=29), Group 3 [61-80 years-old] (n=36) © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e571-e572 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Tyler Lu More articles by this author Jaspreet Singh Parihar More articles by this author Bianca Chendrimada More articles by this author Hari S.G.R. Tunuguntla More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...